CIM
MTCR

CIM Investment Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

CIM Investment Management’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,054
Closed -$13K – 314
2021
Q4 		$13K Hold
19,054
– – ﹤0.01% 299
2021
Q3 		$65K Hold
19,054
– – 0.02% 298
2021
Q2 		$72K Hold
19,054
– – 0.02% 298
2021
Q1 		$118K Buy
+19,054
New +$169K 0.04% 296

Other funds holding MTCR

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIM Investment Management's MTCR Position: Q1 2022 in Review

CIM Investment Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2022, closing a stake of 19,054 shares — an estimated $13K sold.

CIM Investment Management first reported a position in MTCR in Q1 2021 and held it in 4 quarters. The position peaked at $118K in Q1 2021. 31 funds tracked by Wall St. Rank hold MTCR as of Q1 2022.

  • CIM Investment Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • CIM Investment Management sold 19,054 Metacrine, Inc. Common Stock shares in Q1 2022, an estimated $13K.
  • CIM Investment Management first reported a position in Metacrine, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • CIM Investment Management's Metacrine, Inc. Common Stock position peaked at $118K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2022.

Based on CIM Investment Management's 13F filing for Q1 2022, filed 17 May 2022.